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AbsTrACT
Objective To explore social workers’ and medical 
advisors’ accounts of genetic testing in adoption.
Methods A qualitative study using semi-structured 
interviews to gather in-depth accounts of retrospective 
cases. Data were analysed thematically to identify 
professionals’ knowledge and expectations.
results Twenty professionals working in adoption 
services (including 8 medical advisors and 12 social 
workers) participated in this study. Social workers 
adopted an essentialist (single-gene) model to discuss 
genetic testing in relation to past cases. They assumed 
that testing was a generic procedure for detecting the 
presence or absence of a specific aetiology, the results 
of which were believed to be definitive and mutually 
exclusive. By contrast, medical advisors were circumspect 
and agnostic about the meaning of results, especially 
in relation to chromosomal microarray testing. Whereas 
social workers believed that genetic testing provided 
clarity in assessment and therefore assisted adoption, 
medical advisors emphasised the uncertainties of testing 
and the possibility that prospective adopters might be 
misled. Medical advisors also reported inappropriate 
requests to test children where there was a family 
history of a genetic condition, or to confirm or exclude a 
diagnosis of fetal alcohol spectrum disorder in children 
presenting with non-specific dysmorphic features.
Conclusion Recent advances in genetic technologies 
are changing the ways in which professionals understand 
and tolerate uncertainty in adoption. Social workers 
and medical advisors have different understandings 
and expectations about the clinical utility of genetic 
testing. These findings have implications for social work 
training about genetic testing and enabling effective 
communication between professional groups.
InTrOduCTIOn
Adopted children are a diverse paediatric popula-
tion. Many present with complex physical, devel-
opmental and/or health-related problems.1–4 For 
each child entering the looked-after system, and 
for whom adoption is the agreed plan, an initial 
health assessment by a medical advisor is a statutory 
requirement.
There are two circumstances in which assess-
ment may involve clinical genetic assessment. First 
is when a child has a clinical problem or physical 
features that suggest the condition may be genetic 
in origin. Paediatricians and clinical geneticists may 
agree that a child can be tested to obtain a diagnosis 
to account for their problem. The second circum-
stance arises when a looked-after child has a family 
history of a genetic disorder that is not apparent 
but which that child might either develop later or 
transmit to their own children in the future. Such 
circumstances can be further divided into clinical 
assessment that may involve carrier or predictive 
genetic testing.
Carrier testing is usually carried out on unaf-
fected individuals at risk of recessive or sex-linked 
conditions, such as cystic fibrosis or haemophilia. 
While there may not be any direct health implica-
tions, a positive result will affect future reproductive 
decisions. Predictive testing applies to autosomal 
dominant conditions usually with late onset, such 
as Huntington’s disease. Testing positive means the 
individual will develop the disorder, although onset 
is variable. In such cases, the general consensus in 
the genetics community is that children should not 
be tested unless there is a clear medical benefit in 
doing so. If there is no medical benefit, then chil-
dren should not be tested because it removes their 
autonomy and their right to an open future. The 
recommendation is that children should be given 
the choice of genetic testing when they are capable 
of making their own decisions.5–8
What is already known on this topic?
 ► Looked-after children are a diverse paediatric 
population that present with complex physical, 
developmental and/or health-related problems.
 ► While recent advances in genome-wide testing 
have increased diagnostic yield, they also pose 
new challenges to paediatrics and adoption.
 ► Clinical significance of chromosomal 
abnormalities is not well understood, which 
raises concerns that its detection among 
looked-after children can be misleading and 
potentially stigmatising.
What this study adds?
 ► Interviews with social workers and medical 
advisors reveal different understandings and 
expectations about the clinical utility of genetic 
testing in adoption.
 ► Medical advisors were circumspect and agnostic 
about the meaning of results, while social 
workers believed that genetic testing provided 
clarity and therefore assisted adoption.
 ► This study suggests that targeted training would 
assist social work and medical professionals to 
communicate more effectively about the use of 
genetic technologies in adoption.
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The recent introduction of next-generation sequencing technol-
ogies has substantially increased both the coverage and resolution 
of genetic information. While genetic testing may refer to relatively 
targeted investigations involving the search for mutations in one 
or more specific genes, ‘genome-wide’ testing can identify multiple 
variants across the entire genome. Recent advances in diag-
nostic testing pose challenges to paediatrics and adoption as new 
methods—microarray-based comparative genomic hybridisation 
(aCGH)—have largely replaced the light microscopy approach to 
chromosome analysis as the first-line investigation for identifying 
a likely cause of a child’s developmental, learning and behavioural 
difficulties.9 10 Microarray can be used to quickly scan a genome 
for chromosomal imbalances at a very high level of resolution.11 
The increased sensitivity of detecting small deletions and duplica-
tions (collectively known as copy number variations (CNVs)) has 
improved diagnostic yield from 3% in traditional karyotype testing 
to approximately 10%–15% in aCGH.10 12 It also means that for 
a significant proportion of cases, diagnostic testing still fails to 
identify a genetic cause, which challenges the widely held assump-
tion that genetic testing is definitive and straightforward.9 In fact, 
genome-wide screening can produce four types of outcome: finding 
a diagnosis for the clinical problem, finding no abnormality, finding 
something of unknown significance or finding an abnormality of 
likely clinical importance but not causing the clinical problem at 
hand (known as an incidental finding).13
The clinical utility of diagnostic genetic testing is further clouded 
by the fact that a negative result does not unequivocally rule out 
a genetic cause because aCGH can only detect copy number 
changes—it cannot detect changes (variants) within genes.14 More-
over, the detection of a variant in a child or parent does not mean 
it has necessarily caused the specific problem because the clinical 
significance of some CNVs is not well understood. For instance, 
a microdeletion within 15q11.2 is commonly associated with a 
wide range of features including autistic traits and learning difficul-
ties.15 However, variable expressivity and incomplete penetrance 
in populations suggests that this microdeletion is not necessarily 
causal, which has raised concerns that its detection among looked-
after children can be misleading and potentially stigmatising.16
Fetal alcohol spectrum disorder (FASD) is a common 
embryopathy found more frequently among looked-after chil-
dren.17 Clinical diagnostic criteria include evidence of maternal 
alcohol, intellectual disability, growth restriction and dysmor-
phic facial features. Diagnosis is challenging, however, because 
there is no reliable biomarker, clinical features are non-specific 
and there may be insufficient information about the pregnancy. 
Futhermore, the associated dysmorphic features overlap with 
features found in some chromosomal disorders.9 For these 
reasons, the use of aCGH is a valid attempt to exclude other 
possible causes of developmental problems and dysmorphic 
features, but the absence of an abnormality is not a direct 
confirmation of FASD.18 The British Medical Association guide-
lines support the involvement of clinical genetics in gathering 
evidence of perinatal history and performing careful examina-
tion of dysmorphic features before proceeding with genetic 
testing.19
As chromosomal microarray testing becomes a mainstream 
diagnostic technology, there are concerns that non-genetics 
professionals, especially those working within social services, 
may not be fully informed about the limitations of a genetic test 
result.16 Some may believe that genetic testing supersedes clinical 
assessment and removes uncertainty about a child’s present or 
future health. The aim of this study was to explore the knowl-
edge and expectations of social workers’ and medical advisors’ 
accounts of genetic testing in adoption.
MeThOds
Twenty participants were recruited through purposive sampling 
of social workers (n=8), social work managers (n=4) and medical 
advisors/community paediatricians (n=8) working in adop-
tion services in Wales. Social workers were contacted through 
the National Adoption Service, all of whom were self-selecting 
as having first-hand experience of cases that involved genetic 
testing. Medical advisors working in each of the local author-
ities were contacted individually via email. Snowball sampling 
techniques were used to contact specific participants who were 
singled out as having relevant experience; this widened our 
recruitment to England. Medical advisors were all mid-to-late 
career, social workers were more diverse, ranging from the 
newly qualified to those with over 30 years’ experience. Table 1 
presents participant characteristics including the number of cases 
they discussed in relation to genetic testing. The asterisk (*) 
symbol indicates where participants discussed cases generically.
Semi-structured qualitative interviews were used to gather 
detailed accounts of retrospective cases. Treating research inter-
views as ‘accounts’ recognises that interviews are more than 
representations of past events and experiences, but complex 
social activities oriented to performing certain actions in the 
present, such as explaining or defending the speaker’s conduct 
or practical reasoning.20 Interviews explored a range of issues 
concerning: past cases of preadoption genetic testing, circum-
stances that trigger a genetic investigation, procedures for 
recording and communicating genetic information between 
professionals, practices of sharing information with prospective 
adopters, the impact of genetic information on postplacement 
experiences and whether a genetic diagnosis disadvantages a 
child’s prospects for adoption. All the interviews lasted between 
60 and 90 min, were audio-recorded and subsequently tran-
scribed verbatim.
Transcripts were coded via an iterative process of reading 
and noticing relevant phenomena, allowing the analyst (first 
author) to arrange data according to differences, commonalities 
Table 1 Participant characteristics
social workers
Code role Gender experience no. of cases Location
SWM01 Social work manager Female 27 years 1 West Wales
SWM02 Social work manager Female 16 years 3 South Wales
SWM03 Social work manager Female 22 years * South Wales
SWM04 Social work manager Male +20 1 London
PAS01 Postadoption support Female +20 2 South Wales
CSW01 Child social worker Female 1 year 1 West Wales
CSW02 Child social worker Male 14 years 5 South Wales
CSW03 Child social worker Male 4 years 1 West Wales
CSW04 Child social worker Female 14 years 3 West Wales
CSW05 Child social worker Female +30 years 2 South Wales
CSW06 Child social worker Male 4 years 1 South Wales
CSW07 Child social worker Female 2 years 1 West Wales
Medical advisors
MA01 Community 
paediatrician
Female – 3* Midlands, 
England
MA02 Paediatric consultant Male 14 years 5* South West 
Wales
MA03 Medical advisor Female 26 years 6* West Wales
MA04 Community 
paediatrician
Female – 2* South Wales
MA05 Medical advisor Female – 5* South Wales
MA06 Designated doctor Female 20 years 9* South Wales
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and structures. Coded selections of data were compiled into a 
subcorpus for group discussion (involving all three authors). 
Data extracts were then selected in order to identify and illus-
trate ‘themes’ relating to implicit assumptions and expectations 
that underpin professionals’ accounts of genetic testing. Each 
of the major themes represent a range of statements about the 
reasons given for, and presumed outcomes of, genetic testing in 
adoption (tables 2 and 3).
resuLTs
‘Genetic testing offers definitive and mutually exclusive 
outcomes’
Social workers often described ‘genetic testing’ as a generic tech-
nical procedure, and were generally unaware of recent advances 
in genome-wide (microarray) testing. A significant finding of 
the study was that social workers employed a single-gene model 
to discuss the outcomes of testing in relation to past adoption 
cases. They assumed that testing was a procedure for detecting 
the presence or absence of a specific aetiology, the outcomes of 
which were definitive and mutually exclusive.
A normal result means that a child does not have a genetic disorder
When social workers described cases of children referred for 
diagnostic testing, they interpreted the results of an investigation 
as a clear and definite outcome. For instance, a normal result 
was thought to discount genetic factors and imply non-genetic 
reasons for a child’s difficulties: “no genetic abnormality found. 
Table 2 Social workers’ accounts of genetic testing in adoption
Themes Illustrative accounts
1. Genetic testing offers definitive and mutually exclusive outcomes
(a) A normal result means that a child does not  
have a genetic disorder
SW: So I know she had a genetic test…
I: But what happened with that? What was the result?
SW: I think it came out fine.
I: What do you mean by fine?
SW: Well, no genetic abnormality found. So we had to sort of then look for a family who would take a child with 
developmental delay. (CSW05)
(b) A result offers clarity about the child’s genetic status I think, mostly, the social workers take their lead from the medical advisors. But I suppose you could be in a 
situation where social workers are finding it hard to find a placement for a child and feel that if they had a genetic 
test then it would be more clear, and some families might feel that it could be something that they could deal 
with. (PAS01)
(c) Genetic testing can reassure prospective adopters I think it reassured the adoptive parents (…) I think that now that the testing has taken place and that nothing 
was found, again that’s offered them some reassurance that, okay, you know, there isn’t a genetic reason for this, 
the delay. (CSW04)
2. Genetic testing can confirm or exclude a specific aetiology
(a) Genetic testing can confirm or exclude a diagnosis if there 
is a family history of a genetic condition
I think it’s easier when you’re trying to confirm a specific thing actually, because you’re looking for a very specific 
issue which you can then rule out or in. (CSW03) 
We tend to use it to eliminate something, like the blood condition. You know, that’s how we’ve seen them used, to 
eliminate a particular thing. (CSW03)
(the medical advisor) felt that (diagnostic testing) would be intrusive and that it wasn’t something that she 
would be pursuing or recommending. However, we did pursue it. The paediatrician saw the child and I think the 
foster carers were more observant and felt maybe possibly there was a slight delay with the speech. I think they 
were looking possibly very much under the microscope and ordinarily wouldn’t have picked up on these issues 
because they weren’t significant. However, the little girl was eventually tested and indeed she did have the same 
chromosome issue as her older sister. (CSW05)
(b) Genetic testing can confirm or 
exclude a diagnosis of FASD
So it’s not a routine thing but it’s something that social workers always have in the back of their minds. And our 
children have regular medicals via an adoption medical or looked-after medical, so they’re starting to look now for 
foetal alcohol (syndrome). I think that’s becoming more possible to test for now. (SWM02)
(c) Genetic testing investigates a specific aetiology I signed consent for a genetic test a little while ago which had been court ordered (^^^) because again of the 
lifelong implications we are always very very careful about what we sign for, but the court had ordered it so, on 
that basis I have to sign for it, I have to sign consent as the corporate parent um (pause) but in terms of informed 
consent what I believed I was signing for was an investigation in relation to a specific condition, now what you’ve 
told me there that actually that could have thrown anything up, I was consenting to one investigation not an 
investigation of various different things, so that’s a really interesting point, that something I need to consider, 
because what am I actually consenting to. (SWM03)
3. Genetic testing can facilitate adoption The more information you’re able to give then the better.  And I would say that the genetic testing would fall 
within that bracket (CSW04) 
There’s a possibility that being able to test might make it possible to find a family whereas not being able to test 
the uncertainty might make it very unlikely that you would find a family. (CSW02)
I: So as the family finder, if the test had been done it would have helped the—
SW: It would have helped me. I feel so, definitely. I know a lot of people don’t agree with that and geneticists 
usually don’t, but for me I’ve found it’s much better to know than not know.
I: Right, even if the tests were positive that the child has a difficulty?
SW: Yeah.
I: That still makes it easier to place?
SW: Yes, definitely. (CSW05)
I don’t know if this is a possibility but I suppose if you’re looking at routinely genetically testing every child where 
there weren’t any issues or concerns it could disadvantage them, couldn’t it? If they are revealing things that you 
perhaps wouldn’t have worried about before. But I think for children where there are already concerns there, then 
I think having a diagnosis can only help them really. (CSW06)
 FASD, fetal alcohol spectrum disorder; SW, social worker. 
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So we had to sort of then look for a family who would take a 
child with developmental delay”.
Several medical advisors reported that children referred for 
microarray testing often receive normal results. Rather than 
discounting a genetic explanation, advisors were more agnostic 
about the meaning of results: “what is normal one day might not 
be normal the next”. A normal result was relative to the limita-
tions or sensitivity of the technology. Only after considering 
Table 3 Medical advisors’ accounts of genetic testing in adoption
Themes Illustrative statement(s)
1. Genetic testing is neither definitive nor deterministic
(a) A ‘normal’ result does not 
necessarily exclude a genetic 
disorder
And that’s the way that we do explain it is that we all have something or there may be something in all of us that we don’t have any 
idea what it means at this point in time but in the future there may be more information. And I think it’s trying to explain that, you know, 
genetics is moving so fast isn’t it that what we have one day is not necessarily, you know, what is normal one day might not be normal the 
next. (MA04)
(b) A ‘positive’ result does not 
necessarily confirm a genetic 
disorder
I think you’ve got to be very careful about testing children just because we can. I think you have to think carefully about what a positive 
result would mean, and I think you mentioned the fact that you can see phenotypic variability. So even if we test a very young child because 
we can, based upon  a family history, and we find a positive result, in terms of then predicting what this is going to mean for the child, I 
think that’s extremely difficult. (MA02)
 
Yes I have had one (VUSs) where I have got the results the day before panel, the adopters knew it was coming but it was something that 
was unknown significance and all I did was ask the panel if I could have time to talk to them before they came into panel to explain that to 
them. And it is like anybody else, you know, it’s sort of saying that there is this, we don’t know what it means, nobody knows what it means 
at this point of time, it may mean something or nothing. (MA04)
(c) Adopters and social workers 
have unrealistic expectations of 
genetic testing
And that’s the other thing that we do tell them (social workers) is when we are doing these (tests) is that, you know, we might be looking 
for something and we pick up something completely different (…) And what all of that means is very difficult and I think they think it’s 
much more simple. (MA04)
 
So these are the two (cases of genetic testing) where the social worker wanted (it) because (for) some unknown reason, in their head, 
they’re thinking if all the boxes are ticked that they can get an adopter. And my question is an adopter should accept the unknown. When 
you have a birth child, you will accept the unknown and so is the unknown because we can’t give answers for all the questions. (MA03)
 
But I think there is this expectation that we can sort of give adopters as much, and rightly so, as much information as we can. But 
sometimes that is about, yes there is this risk and trying to quantify that risk and to help them to learn to live with that risk rather than 
saying, yes it is or no it’s not and I think that’s the difficult thing. (MA04)
 
I think a lot of the local authority members and a lot of adoption panel members felt that the children in this family should be tested 
because if they were tested negative it would all be fine. And what they couldn’t quite understand was, yes but if they are tested and 
positive the implication for that child and that child has now the choice of knowing has been taken away from them and it’s sometimes 
difficult for lay people to understand why we do or we don’t do things. (MA04)
2. Genetic testing is inappropriate:
(a) if the child is unaffected but 
there is a family history  
of genetic risk
I have dealt with a few issues in (place) where the father had said he had Noonan syndrome and the child didn’t have any evidence. And 
the child did not have and the social worker wanted this child to be tested genetically and I didn’t think it was appropriate so I dug my heel 
in. I said, tell me what you going to do with that? The child does not have any symptoms and why should I do it? (…) The solicitor spoke to 
me and I said look there is no signs, there’s no evidence of cardiac problem, any other problem. She might have learning difficulties but the 
mother and father has learning difficulties and for me, just tell me where the father’s diagnosis was made. (MA03)
One (case) I can think of is where there has been a family history of Charcot-Marie-Tooth where there has been huge pressure from the local 
authority to undertake genetic testing and we are, it’s felt, and in discussion with genetics, it’s not appropriate to do so because the child 
themselves have got no symptoms. There is nothing we are going to do about it, we aren’t going to treat anything at this point in time, and 
that the testing should be done at a later date if it is necessary. (MA04)
(b) to confirm or exclude  
a diagnosis of FASD
We’re having requests for children to be tested for conditions. For example, recently, I’ve heard that guardian was pushing for an expert 
assessment of a child, who she felt needed to be tested for foetal alcohol syndrome, which clearly—well there is no clinical investigation 
that’s going to give us than answer. Obviously, there is an examination we can do, there’s a history we can consider, but I had seen that 
child for an adoption medical and it was clear to me that that child didn’t have foetal alcohol syndrome. Whether there might be foetal 
alcohol effects further down the line, that’s another factor if there were concerns about the mum drinking, but there was certainly nothing 
that I saw that would warrant any further assessment but the guardian had pushed for, this child needs a test. (MA02)
 
That is what I heard, somebody was saying that one particular judge was demanding genetic testing for foetal alcohol syndrome. Not here, 
I didn’t have it. (…) one of the doctors did mention that they were asked to do a genetic test for foetal alcohol syndrome and that was 
demanded by the judge. So we were discussing about educating the judges and then somebody said they had the difficult group to educate. 
(Laughs) (MA03)
 
I couldn’t quite quantify it exactly but a lot of these cases we will do them on are babies where their mums have been drinking during 
pregnancy and they have got dysmorphic features and we are looking to exclude other courses other than foetal alcohol, and that’s a big 
one for us. (…) we are trying to exclude other causes of the dysmorphic features and therefore because, you know, at this point in time we 
can’t diagnose foetal alcohol syndrome directly it’s let’s exclude everything else, so that is the reasoning behind it. (MA04)
3. Genetic testing can complicate  
or hinder adoption
I think it’s quite a challenge for them (social workers) to understand then the pros and the cons of genetic testing because clearly their 
thought is around finding an adoptive placement for a child and doing what they can to facilitate that, and that might be a thought that 
well if we arrange genetic testing, particularly if a test result is negative, well that might be helpful in terms of then a child finding adopters. 
I guess the flip side of that is well what happens if the test result is positive? Might that make it more difficult, and who is this test for? Is 
this a test for the adopters or is this a test for the child? (MA02)
FASD, fetal alcohol spectrum disorder. 
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family history and clinical judgement did medical advisors infer 
non-genetic causes.
A (positive) result offers clarity about the child’s genetic status
Some social workers described cases in which a positive result 
offered clarity about the child’s genetic status. For instance, 
the detection of a chromosomal abnormality was described as 
a specific aetiology that explained the child’s condition. While 
in some cases that would be true, in other cases social workers 
conceded that the clarity of the result was offset by variability of 
the phenotype, that is, it was uncertain“how the disorder would 
manifest itself ”.
Medical advisors were far more circumspect about a positive 
result. The detection of a chromosomal abnormality was not a 
definitive answer, as one advisor put it. Variants found in the 
general population do not mean that its detection in an indi-
vidual was necessarily pathogenic: “there are lots of people in 
the general population that have these small changes and they 
do not impact on them in any way”. In other cases, variants of 
unknown significance were explained to prospective adopters as 
inherently uncertain (table 3.1b).
Genetic testing can assist adoption
Although some social workers were ambivalent about genetic 
testing (“I don’t know if genetic testing is going to help me find 
a good home for this child”), many believed that it can assist 
adoption by removing uncertainty about the child’s health. 
They explained that most adopters were averse to uncertainty, 
and described situations in which an impending genetic inves-
tigation had “put off ” adopters. For these reasons, informa-
tion was considered to be beneficial to adoption. One social 
worker described genetic testing as simply “more informa-
tion” (table 2.3) with which to alleviate adopters’ concerns.
These views were sharply contrasted by the medical advisors 
who were concerned that adopters could be misled into thinking 
that testing would necessarily yield clear and definitive results 
(table 3.1b). An argument frequently made by adoption services 
is that genetic testing will make it easier to place a child with 
a family. However, one medical advisor countered this view 
(table 3.3)
‘Genetic testing can confirm or exclude a specific aetiology’
Many social workers claimed that genetic testing could be used 
to confirm or exclude a specific aetiology. Clinical utility was 
overestimated because it was assumed that genetic causes were 
singular and that detection was straightforward. An illustration 
of this was provided by one senior social worker: “I think it’s 
easier when you’re trying to confirm a specific thing actually, 
because you’re looking for a very specific issue which you can 
then rule out or in” (table 2.2a) While this applies to the second 
category of genetic assessment (see above), the metaphor of 
ruling in or ruling out a genetic condition does not apply well to 
the first category; social workers were inclined to oversimplify 
causality as either genetic or non-genetic.
Genetic testing can confirm or exclude a diagnosis if there is a 
family history of a genetic condition
Referrals for genetic testing may arise if a child is presenting 
with problems alongside a family history of a (suspected) genetic 
condition. However, social workers reported several cases in 
which diagnostic testing of unaffected children had occurred on 
the basis of family history alone. One social worker described 
a case in which adopters had pursued genetic testing because a 
chromosomal abnormality had been detected in an older sibling. 
Against the recommendations of the medical advisor, "the little 
girl was eventually tested and indeed she did have the same chro-
mosome issue as her older sister".
All the medical advisors we interviewed reported cases 
involving inappropriate requests for genetic testing. One advisor 
described how a social worker had initiated a court order to test 
an unaffected child based on unverified information that the 
birth father had Noonan syndrome. Another advisor described a 
similar case involving a family history of Charcot-Marie-Tooth. 
Implicit to these requests was the assumption that testing for a 
family mutation would confirm or exclude a genetic diagnosis in 
the child (table 3).
Genetic testing can confirm or exclude a diagnosis of FASD
Social workers indicated that FASD affecting looked-after 
children was a growing concern. For children presenting with 
non-specific dysmorphic features, establishing a definitive diag-
nosis was considered important for assessment and adoption. 
One social worker believed that genetic testing could be used to 
diagnose FASD (table 2.2b).
Microarray testing was described by several medical advisors as 
a procedure for excluding chromosomal abnormalities in order 
to assist diagnosis. Although they insisted that genetic testing 
should not replace clinical judgement, one medical advisor indi-
cated that social workers were misled in thinking that there was 
a test for FASD (table 3). Another medical advisor explained 
that, because microarray was used as a kind of ‘negative test’ 
for FASD, there was a tendency to overuse it in the clinic: “I 
think if the case is strong history of using alcohol heavily during 
pregnancy, if the child is showing from birth some indication that 
he or she would be foetal alcohol syndrome … why should I do 
an array CGH?”
dIsCussIOn
The study found that social workers often described ‘genetic 
testing’ as a generic procedure for detecting the presence or 
absence of a specific aetiology, the results of which were believed 
to be definitive and mutually exclusive. In the absence of specific 
knowledge about genetic testing, social workers adopted an 
essentialist model (a sociocognitive heuristic that assumes simple 
causality and gene determinism) to make sense of past cases.21 
Although some displayed knowledge of gene expression and 
gene-environment interaction, social workers assumed that 
genetic testing offered clarity in adoption because it removed 
uncertainty about the child’s health. Many explained that these 
uncertainties were unpalatable to a majority of adopters.
It was not unexpected to find that medical advisors were 
better informed about genetic testing and therefore recognised 
that many genetic conditions are multifactorial. Indeed, they 
were far more circumspect and agnostic about the outcomes 
of genetic testing, especially the results of aCGH. Rather than 
reducing uncertainties about the child, many advisors explained 
that uncertainty was an unavoidable outcome of assessment, and 
often at odds with the knowledge and expectations of social 
workers and prospective adopters. Cases that involved reporting 
variants of unknown significance were described as unwelcome 
outcomes that required careful and sensitive communication.
Medical advisors also reported multiple cases involving 
inappropriate requests for testing from social workers, special 
guardians, prospective adopters and legal professionals. There 
was apparently a general misconception that genetic testing was 
capable of confirming or excluding a genetic condition in the 
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child. In some cases, testing was pursued for unaffected chil-
dren on the basis of family history. Medical advisors expressed 
concerns that testing unaffected children was medically and 
ethically inappropriate as well as an unsuitable strategy for diag-
nosing complex, multifactorial conditions.
The study also revealed cases in which social workers and 
legal professionals believed in the existence of a genetic test for 
FASD. This may arise from the fact that some medical advisors 
use microarray to exclude chromosomal abnormalities in chil-
dren presenting with dysmorphic features. However, several 
medical advisors stressed that diagnostic testing for FASD should 
be approached with caution. Where there is clinical suspicion of 
FASD, children should receive formal clinical assessment as well 
as detailed assessment of the available family before deciding 
to pursue a genetic investigation. Even then, the outcomes may 
have limited clinical utility and may affect the child’s prospects 
of adoption. A negative aCGH result could be misinterpreted as 
confirming a diagnosis of FASD, while finding a microdeletion 
of reduced penetrance could be taken inappropriately as under-
mining the same diagnosis.
COnCLusIOn
This study explores the ways in which different professional 
groups make sense of genetic assessment in adoption. Social 
workers and medical advisors play a crucial role in ensuring 
that vulnerable children are properly assessed and supported to 
achieve permanency with an adoptive family. However, recent 
advances in genetic technologies, notably the shift from genetic 
to genomic testing, are changing the ways in which professionals 
understand and tolerate uncertainty. This study reveals cases in 
which social workers and medical advisors have different under-
standings and expectations about the clinical utility of genetic 
testing. The priority for social workers is to use health infor-
mation to increase the transparency of information about the 
child in order to secure their placement with a suitable family. In 
many cases, information regarding medical and developmental 
uncertainties is construed as obstacles to the adoption process. 
The priority for medical advisors is to report these uncertainties 
as and when they apply, to place the risks of the child in context 
and to protect the child’s future autonomy from unnecessary 
testing. The findings suggest that social workers would benefit 
from specific training on the ethical and technical aspects of 
genetic and genomic testing, while multidisciplinary team meet-
ings would provide a practical forum to discuss the contrasting 
priorities of adoption professionals.
Correction notice This paper has been amended since it was published Online 
First. There were some incorrect table citations which have now been corrected.
Contributors All the authors have made a material contribution to writing and 
drafting of the paper. However, MA-A made a substantial contribution towards 
writing, data analysis and conceptualisation. MA-A is also the grant holder of the 
project on which the paper is reporting. 
Funding This work was supported by the Wellcome Trust grant number 
205644/Z/16/Z.
Competing interests None declared.
ethics approval This study was approved by School of Social Sciences Research 
Ethics Committee of Cardiff University (SREC/2229). 
Provenance and peer review Not commissioned; externally peer reviewed.
data sharing statement The interview data collected for this study are only 
available to the collaborators of the project who are the three authors cited in this 
submission.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits 
others to copy, redistribute, remix, transform and build upon this work for any 
purpose, provided the original work is properly cited, a link to the licence is given, 
and indication of whether changes were made. See: https:// creativecommons. org/ 
licenses/ by/ 4. 0/.
RefeRences
 1 Children looked after in England. Department for education. 2018 https:// assets. 
publishing. service. gov. uk/ government/ uploads/ system/ uploads/ attachment_ data/ file/ 
757922/ Children_ looked_ after_ in_ England_ 2018_ Text_ revised. pdf (Accessed 15 
Dec 2018).
 2 Wales Children in need Census. Statistics for wales. 2015 https:// gov. wales/ statistics- 
and- research/ wales- children- need- census/? lang= en (accessed 14/08/2016).
 3 Wales children receiving care and support census. 2017 https:// gov. wales/ docs/ 
statistics/ 2018/ 180319- wales- children- receiving- care- support- census- 2017- en. pdf 
(Accessed 15 Dec 2018).
 4 Bramlett MD, Radel LF, Blumberg SJ. The health and well-being of adopted children. 
Pediatrics 2007;119(Suppl 1):S54–S60.
 5 British Society of Human Genetics (BSHG). Genetic testing of children. Report of a 
working party of the British Society for Human Genetics 2010.
 6 Borry P, Evers-Kiebooms G, Cornel MC, et al. Genetic testing in asymptomatic minors: 
background considerations towards ESHG Recommendations. Eur J Hum Genet 
2009;17:711–9.
 7 European Society of Human Genetics (ESHG). Genetic testing in asymptomatic minors: 
recommendations of the European Society of Human Genetics. Eur J Med Genet 
2009;17:720–1.
 8 Committee on bioethicscommittee on genetics, and american college of medical 
genetics and genomics social ethical legal issues committee. Ethical and policy issues 
in genetic testing and screening of children. Pediatrics 2013;131:620–2.
 9 Parker MJ, Teasdale K, Parker MJ. The genetic assessment of looked after children: 
common reasons for referral and recent advances. Arch Dis Child 2016;101:581–4.
 10 Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray 
is a first-tier clinical diagnostic test for individuals with developmental disabilities or 
congenital anomalies. Am J Hum Genet 2010;86:749–64.
 11 Theisen A. Microarray-based Comparative Genomic Hybridization (aCGH). Nature 
Education 2008;1:45. 
 12 Grozeva D, Carss K, Spasic-Boskovic O, et al. Targeted next-generation 
sequencing analysis of 1,000 individuals with intellectual disability. Hum Mutat 
2015;36:1197–204.
 13 Briggs TA, Harris J, Innes J, et al. The value of microarray-based comparative genomic 
hybridisation (aCGH) testing in the paediatric clinic. Arch Dis Child 2015;100:728–31.
 14 Manning M, Hudgins L. Professional Practice and Guidelines Committee. Array-based 
technology and recommendations for utilization in medical genetics practice for 
detection of chromosomal abnormalities. Genet Med 2010;12:742–5.
 15 Burnside RD, Pasion R, Mikhail FM, et al. Microdeletion/microduplication of proximal 
15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction 
including developmental and language delay. Hum Genet 2011;130:517–28.
 16 Hamilton MJ, Tolmie JL, Joss S, et al. Chromosomal microarray analysis for looked after 
children: a double-edged sword? Arch Dis Child 2015;100:206–7.
 17 Douzgou S, Breen C, Crow YJ, et al. Diagnosing fetal alcohol syndrome: new insights 
from newer genetic technologies. Arch Dis Child 2012;97:812–7.
 18 Jamuar SS, Picker JD, Stoler JM. Utility of genetic testing in fetal alcohol spectrum 
disorder. J Pediatr 2018;196:270–4.
 19 BMA. Fetal Alcohol Spectrum Disorders, a guide for health professionals. BMA Board 
of Science 2007.
 20 Arribas-Ayllon M, Sarangi S, Clarke A. Professional ambivalence: accounts of ethical 
practice in childhood genetic testing. J Genet Couns 2009;18:173–84.
 21 Dar-Nimrod I, Heine SJ. Genetic essentialism: on the deceptive determinism of DNA. 
Psychol Bull 2011;137–800–18.
 o
n
 7 August 2019 by guest. Protected by copyright.
http://adc.bmj.com/
Arch D
is Child: first published as 10.1136/archdischild-2019-316911 on 11 July 2019. Downloaded from
 
